ScottCHowardMD
Pediatric Hematology & Oncology • Memphis, TNAssociate Professor of Medicine, University Tenn College of Medicine
Are you Dr. Howard?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 73 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
St Jude Childrens Research Hospital
262 Danny Thomas Place
Memphis, TN 38105Phone+1 901-595-2972Fax+1 901-595-2972
Summary
- Dr. Scott Howard, MD is a pediatric hematologist/oncologist in Memphis, Tennessee. He is currently licensed to practice medicine in Tennessee. He is affiliated with St. Jude Children's Research Hospital and is an Associate Professor of Medicine at University Tenn College of Medicine.
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 1998 - 2001- University of TennesseeResidency, Internal Medicine/Pediatrics, 1994 - 1998
University of Alabama School of MedicineClass of 1994
Certifications & Licensure
TN State Medical License 1995 - 2024
Clinical Trials
- AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone Start of enrollment: 2001 Jul 01
- Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients Start of enrollment: 2009 Aug 01
Publications & Presentations
PubMed
- Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity.Gabriela Villanueva, Jennifer Lowe, Nicolás Tentoni, Ankit Taluja, Milena Villarroel
Pediatric Hematology and Oncology. 2024-01-01 - 1 citationsSevere Methotrexate Toxicity Following a Capizzi Cycle in an Obese Adolescent With Acute Lymphoblastic Leukemia and Hepatic Steatosis.Julie M Fischer, Oranooj Lertkovit, Scott C Howard, Chatchawin Assanasen, Archie Bleyer
Journal of Pediatric Hematology/oncology. 2024-01-01 - 2 citationsExpert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel.Anthony J Perissinotti, Michael R Bishop, Joseph Bubalo, Mark B Geyer, Amy Goodrich
Cancer Treatment Reviews. 2023-11-01
